According to the methods in our previous report [11 (link)], the eluted peak of A1 (Fig. 1a) containing antimicrobial activity was pooled, lyophilized, and further purified by RP-HPLC on a Wondasil C18 column (25 × 0.46 cm). The elution was performed using a linear gradient of 0–60 % acetonitrile containing 0.1 % (v/v) trifluoroacetic acid in 0.1 % (v/v) trifluoroacetic acid/water over 70 min. N-terminal sequence of the purified peptide was done by Edman degradation on an Applied Biosystems pulsed liquid-phase sequencer (model ABI 491).

Purification of SibaCec from the salivary gland of S. bannaense and MALDI–TOF MS. a The filtrate of the salivary gland homogenate of S. bannaense was divided by an Inertsil C4 RP-HPLC column. b The eluted peak of A1 containing antimicrobial activity was further purified by C18 RP-HPLC column. The purified SibaCec is indicated by an arrow. c MALDI-TOF mass spectrometry analysis of the purified SibaCec

Free full text: Click here